These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 16603757)

  • 41. Evaluating psychiatric outcomes associated with direct-acting antiviral treatment in veterans with hepatitis C infection.
    Sackey B; Shults JG; Moore TA; Rogers R; Mehvar M; King JG
    Ment Health Clin; 2018 May; 8(3):116-121. PubMed ID: 29955556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Patient-Provider Relationship Is Associated with Hepatitis C Treatment Eligibility: A Prospective Mixed-Methods Cohort Study.
    Rogal SS; Arnold RM; Chapko M; Hanusa BV; Youk A; Switzer GE; Sevick MA; Bayliss NK; Zook CL; Chidi A; Obrosky DS; Zickmund SL
    PLoS One; 2016; 11(2):e0148596. PubMed ID: 26900932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychosocial issues in patients with chronic hepatitis B and C.
    Enescu A; Mitrut P; Balasoiu M; Turculeanu A; Enescu AS
    Curr Health Sci J; 2014; 40(2):93-6. PubMed ID: 25729588
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical utility of pharmacogenomics in the management of hepatitis C.
    Trinks J; Hulaniuk ML; Redal MA; Flichman D
    Pharmgenomics Pers Med; 2014; 7():339-47. PubMed ID: 25382982
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Provider and patient correlates of provider decisions to recommend HCV treatment to HIV co-infected patients.
    Wagner G; Osilla KC; Garnett J; Ghosh-Dastidar B; Bhatti L; Witt M; Goetz MB
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(4):245-51. PubMed ID: 22564797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection.
    Alavi M; Grebely J; Matthews GV; Petoumenos K; Yeung B; Day C; Lloyd AR; Van Beek I; Kaldor JM; Hellard M; Dore GJ; Haber PS;
    J Gastroenterol Hepatol; 2012 May; 27(5):957-65. PubMed ID: 22142332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized controlled trial of an integrated care intervention to increase eligibility for chronic hepatitis C treatment.
    Evon DM; Simpson K; Kixmiller S; Galanko J; Dougherty K; Golin C; Fried MW
    Am J Gastroenterol; 2011 Oct; 106(10):1777-86. PubMed ID: 21769136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Psychiatric and substance use disorders among methadone maintenance patients with chronic hepatitis C infection: effects on eligibility for hepatitis C treatment.
    Batki SL; Canfield KM; Ploutz-Snyder R
    Am J Addict; 2011; 20(4):312-8. PubMed ID: 21679262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychiatric care of the patient with hepatitis C: a review of the literature.
    Rifai MA; Gleason OC; Sabouni D
    Prim Care Companion J Clin Psychiatry; 2010; 12(6):. PubMed ID: 21494349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of chronic hepatitis C in Croatian war veterans: experiences from Croatian reference center for viral hepatitis.
    Papić N; Židovec Lepej S; Kurelac I; Čajić V; Budimir J; Dušek D; Vince A
    Croat Med J; 2011 Feb; 52(1):35-40. PubMed ID: 21328718
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Barriers to accessing care in patients with chronic hepatitis C: the impact of depression.
    Evon DM; Simpson KM; Esserman D; Verma A; Smith S; Fried MW
    Aliment Pharmacol Ther; 2010 Nov; 32(9):1163-73. PubMed ID: 21039678
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessing the STIRR model of best practices for blood-borne infections of clients with severe mental illness.
    Rosenberg SD; Goldberg RW; Dixon LB; Wolford GL; Slade EP; Himelhoch S; Gallucci G; Potts W; Tapscott S; Welsh CJ
    Psychiatr Serv; 2010 Sep; 61(9):885-91. PubMed ID: 20810586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Weight loss, leukopenia and thrombocytopenia associated with sustained virologic response to Hepatitis C treatment.
    Suwantarat N; Tice AD; Khawcharoenporn T; Chow DC
    Int J Med Sci; 2010 Jan; 7(1):36-42. PubMed ID: 20107528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors that influence an HIV coinfected patient's decision to start hepatitis C treatment.
    Osilla KC; Ryan G; Bhatti L; Goetz M; Witt M; Wagner G
    AIDS Patient Care STDS; 2009 Dec; 23(12):993-9. PubMed ID: 19929229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treat early or wait and monitor? A qualitative analysis of provider hepatitis C virus treatment decision-making in the context of HIV coinfection.
    Wagner G; Ryan G; Osilla KC; Bhatti L; Goetz M; Witt M
    AIDS Patient Care STDS; 2009 Sep; 23(9):715-25. PubMed ID: 19663714
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of a hepatitis C virus educational intervention or a motivational intervention on alcohol use, injection drug use, and sexual risk behaviors among injection drug users.
    Zule WA; Costenbader EC; Coomes CM; Wechsberg WM
    Am J Public Health; 2009 Apr; 99 Suppl 1(Suppl 1):S180-6. PubMed ID: 19218179
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations.
    Maru DS; Bruce RD; Basu S; Altice FL
    Clin Infect Dis; 2008 Oct; 47(7):952-61. PubMed ID: 18715156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis C treatment of patients with bipolar disorder: a case series.
    Rifai MA
    Prim Care Companion J Clin Psychiatry; 2006; 8(6):361-6. PubMed ID: 17245458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis C treatment eligibility and outcomes among patients with psychiatric illness.
    Rifai MA; Moles JK; Short DD
    Psychiatr Serv; 2006 Apr; 57(4):570-2. PubMed ID: 16603757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care.
    Fireman M; Indest DW; Blackwell A; Whitehead AJ; Hauser P
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S286-91. PubMed ID: 15768336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.